SCO’s support for Fresenius Kabi Swissbiosim from 2017-2019 was exceptional.
They played a vital role in implementing the new biosimilar business into the internal supply network, particularly in demand and supply planning at third-party manufacturing sites. The planning tool developed by SCO was crucial in simulating various supply scenarios and was instrumental in decision-making at the executive level, ultimately leading to a successful product launch.
One of SCO’s most impressive qualities is their expertise in data analysis, which proved to be invaluable in a start-up environment where historical and real-time data were missing. SCO’s extensive network of CMOs also enabled a significantly faster selection and contracting process, which was critical in meeting tight deadlines.
Overall, SCO’s contribution was paramount in the success of Fresenius Kabi Swissbiosim’s initial product launch. Their professionalism, expertise, and collaborative approach were highly appreciated by the team, and I would not hesitate to recommend their services to others in need of support in similar areas.